» Articles » PMID: 21042775

MicroRNA-21 Promotes the Cell Proliferation, Invasion and Migration Abilities in Ovarian Epithelial Carcinomas Through Inhibiting the Expression of PTEN Protein

Overview
Journal Int J Mol Med
Specialty Genetics
Date 2010 Nov 3
PMID 21042775
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

Ovarian cancer, especially epithelial ovarian cancer (EOC), which accounts for 90% of ovarian cancer, continues to be the leading cause of death among gynecological malignancies. However, the factors associated with its malignant biological behavior are still poorly understood. Accumulating evidence suggests that microRNAs (miRNAs), regulating diverse biological processes, may play an important role in tumorigenesis and development. miR-21 has been frequently observed to be aberrantly overexpressed in various tumors. Using real-time PCR, we confirmed that miR-21 was significantly overexpressed in human EOC tissues and cell lines. The overexpression of miR-21 correlated with histological differentiation, clinicopathological stage, and lymph node metastasis, and we showed that knockdown of miR-21 by an inhibitor caused a significant reduction in cell proliferation and decrease in cell migration and invasion abilities. Furthermore, we demonstrated that knockdown of miR-21 significantly increased the expression of PTEN, a known tumor suppressor in ovarian cancer. Collectively, our findings suggest miR-21 may be important in the initiation and progression of EOC as an oncomiR, likely through regulating PTEN.

Citing Articles

MicroRNA as a Potential Diagnostic and Prognostic Biomarker in Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis.

Khanmohammadi S, Masrour M, Fallahtafti P, Hasani F Cancer Rep (Hoboken). 2025; 8(1):e70070.

PMID: 39854617 PMC: 11760998. DOI: 10.1002/cnr2.70070.


An overview of challenges associated with exosomal miRNA isolation toward liquid biopsy-based ovarian cancer detection.

Bhadra M, Sachan M Heliyon. 2024; 10(9):e30328.

PMID: 38707279 PMC: 11068823. DOI: 10.1016/j.heliyon.2024.e30328.


Mechanisms of Regulation of the Expression of miRNAs and lncRNAs by Metformin in Ovarian Cancer.

Alfaro I, Vega M, Romero C, Garrido M Pharmaceuticals (Basel). 2023; 16(11).

PMID: 38004379 PMC: 10674581. DOI: 10.3390/ph16111515.


Unlocking the potential of non-coding RNAs in cancer research and therapy.

Uppaluri K, Challa H, Gaur A, Jain R, Krishna Vardhani K, Geddam A Transl Oncol. 2023; 35:101730.

PMID: 37406550 PMC: 10366642. DOI: 10.1016/j.tranon.2023.101730.


PEGylated nanohydrogels delivering anti-MicroRNA-21 suppress ovarian tumor-associated angiogenesis in matrigel and chicken chorioallantoic membrane models.

Javanmardi S, Abolmaali S, Mehrabanpour M, Aghamaali M, Tamaddon A Bioimpacts. 2022; 12(5):449-461.

PMID: 36381633 PMC: 9596881. DOI: 10.34172/bi.2022.23263.